Bruce Keogh

The European Association for Cardio-Thoracic Surgery was founded in 1986 and is based in Windsor, UK. The British company represents over 4,000 surgeons and aims to advance education in the field of cardiac, thoracic, and vascular interventions. The private company also promotes and disseminate research into cardiovascular and thoracic physiology, pathology, and therapy.

The Society for Cardiothoracic Surgery in Great Britain & Ireland is a professional organization related to cardiac surgery. The non-profit company is based in Great Britain and Ireland.

Birmingham Women's NHS Foundation Trust provides health care services. The non-profit company is based in Edgbaston, UK.

Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.

Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.